El Futuro en el Tratamiento del Cáncer Renal - page 24

A First-in-Human Study of PF-04518600 OX40 Agonist in solid tumors

Diab A, et al. ESMO 2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,14,15,16,17,18,19,20,21,22,23 25,26,27,28,29,30,31,32,33,34,...36